Author | N (XYS vs. HRT) | Age (years) | Outcome | Interventions | Duration | Adverse effects | Follow-up | |
Experimental | Control | |||||||
Huang 2013 [21] | 48/44 | 44.1 | 1) Response rate 2) single symptoms improvement | XYW (TID) | Estradiol (1 mg QD) + Medroxyprogesterone (8 mg QD) | 8 weeks | R | N.R |
Tang 2005 [22] | 322/330 | 45 - 55 | Response rate | XYW (BID) | Nilestriol (1 - 2 mg BIW) | 8 weeks | R | N.R |
Zhang 2014 [23] | 21/21 | 50 | Response rate | XYW (TID) | Estrogen (N.R.) | 3 weeks | N.R. | 3 months |
Hu 2009 [24] | 84/84 | 49.6 | 1) Response rate 2) FSH, E2, LH | DZXYS (QD) | Nilestriol (2 mg BIW) | 12 weeks | N.R. | N.R |
Yun et al. 2015 [25] | 96/96 | 49.7 | 1) Response rate 2) Kupperman Score | DZXYS (BID) | Estrogen and progesterone (N.R.) | 12 weeks | N.R. | N.R |
Liu 2008 [26] | 32/32 | 40 - 60 | Single symptoms improvement | DZXYS (QD) | Premarin (0.3 mg TID) + Medroxyprogesterone (10 mg QD) | 4 weeks | R | N.R |
Zhou 1997 [27] | 120/60 | N.R. | Response rate | DZXYS (QD) | Stilbestrol (0.5 mg QD) + Medroxyprogesterone (4 mg BID) | 12 weeks | N.R. | 2 years |
Wang et al. 2016 [28] | 40/40 | 47 - 55 | Response rate | JWXYS (TID) | Nilestriol (2 mg BIW) | N.R. | R | N.R |
Zhang 2011 [29] | 43/40 | 42 - 54 | Response rate | JWXYW (TID) | Nilestriol (2 mg BIW) | 8weeks | R | N.R |